Search clinical trials for: CDK4/6
Total 7053 results
-
G1 Therapeutics, Inc.Roche-GenentechTerminatedSmall Cell Lung CancerUnited States, Spain, France, Bulgaria, Ukraine, Estonia, Latvia
-
Mansoura UniversityRecruitingBreast Cancer Stage IVEgypt
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
West China HospitalRecruitingEsophageal Squamous Cell CarcinomaChina
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Belgium, Canada, Italy, United Kingdom, Hungary, Taiwan, Australia, Germany, Spain, Austria, Russian Federation, Korea, Republic of, China, France, Brazil, Ireland, Argentina, Romania, Poland
-
Cancer Institute and Hospital, Chinese Academy...OrigiMedUnknown
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Yantai Yuhuangding HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Case Comprehensive Cancer CenterRecruitingSmall-cell Lung Cancer | Large Cell Neuroendocrine Carcinoma of the Lung | Extrapulmonary Small Cell CarcinomaUnited States
-
Children's Hospital Medical Center, CincinnatiNovartisTerminatedHigh Grade Glioma | Diffuse Intrinsic Pontine Glioma | Bithalamic High Grade GliomaUnited States
-
University of CopenhagenClinical Immunological Department, Rigshospitalet; The Danish Blood Donor StudyRecruitingAutoantibodies | Interleukin-6Denmark
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
Centro di Riferimento Oncologico - AvianoRecruitingBreast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene MutationItaly
-
Dana-Farber Cancer InstituteEli Lilly and Company; Effector TherapeuticsRecruitingOvarian Cancer | Endometrial CancerUnited States
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Novartis PharmaceuticalsCompleted
-
Prelude TherapeuticsActive, not recruitingSarcoma | Breast Cancer | Glioblastoma | Malignant Mesothelioma | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung CancersUnited States, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Lebanese UniversityHaykel HospitalRecruitingCancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Chemotherapy | Solid Tumor | Immunotherapy | Targeted Therapy | Precision TherapyLebanon
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
Roswell Park Cancer InstituteRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
Novartis PharmaceuticalsCompleted
-
Keimyung University Dongsan Medical CenterCompletedOttawa Scale <6Korea, Republic of
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruiting
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Breast CancerChina
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Erasca, Inc.Active, not recruitingMetastatic Colorectal Cancer | Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
University of Milano BicoccaCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Canadian Cancer Trials GroupRecruiting
-
The Affiliated Hospital of Qingdao UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Alaa Gameil Abd El-salam HussienAssiut UniversityActive, not recruitingThe Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD PediatricsEgypt
-
Guangzhou Institute of Respiratory DiseaseThe Fifth Affiliated Hospital of Zunyi Medical CollegeCompletedCOPD | Metabolomics | Omega 3 | Omega 6
-
Novartis PharmaceuticalsRecruitingBreast CancerRussian Federation